BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36912944)

  • 1. Low diffusion capacity predicts poor prognosis in extensive stage small cell lung cancer: a single-center analysis of 10 years.
    Kim JS; Kim EJ; Jang JG; Hong KS; Ahn JH
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7275-7283. PubMed ID: 36912944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of amrubicin third-line chemotherapy in patients with relapsed extensive-disease small-cell lung cancer: A retrospective and historical study in a single institute.
    Sonehara K; Tateishi K; Fukushima T; Komatsu M; Yamamoto H; Koizumi T; Hanaoka M
    Thorac Cancer; 2019 Sep; 10(9):1805-1811. PubMed ID: 31350820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [First-line chemotherapy and its survival analysis of 394 patients with extensive-stage small cell lung cancer in a single institute].
    Ma M; Wang M; Xu Y; Hu K; Liu H; Li L; Zhong W; Zhang L; Zhao J; Wang H
    Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):8-14. PubMed ID: 24398308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A lower level of forced expiratory volume in one second predicts the poor prognosis of small cell lung cancer.
    Kang HS; Shin AY; Yeo CD; Kim JS; Kim YH; Kim JW; Lee SH
    J Thorac Dis; 2018 Apr; 10(4):2179-2185. PubMed ID: 29850121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with overall survival, progression-free survival and toxicity in patients with small cell lung cancer and thoracic irradiation in a clinical real-world setting.
    Kassik MT; Vordermark D; Kornhuber C; Medenwald D
    Radiat Oncol; 2023 Apr; 18(1):70. PubMed ID: 37072833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of coexistent chronic obstructive pulmonary disease on the survival of patients with small cell lung cancer receiving chemotherapy.
    Ju S; Lee HR; Kim JY; Kim HC; Lee GW; You JW; Cho YJ; Jeong YY; Lee JD; Lee SJ
    Thorac Cancer; 2018 Oct; 9(10):1271-1278. PubMed ID: 30109781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geriatric Nutritional Risk Index as a prognostic marker in patients with extensive-stage disease small cell lung cancer: Results from a randomized controlled trial.
    Lee GW; Go SI; Kim DW; Kim HG; Kim JH; An HJ; Jang JS; Kim BS; Hahn S; Heo DS
    Thorac Cancer; 2020 Jan; 11(1):62-71. PubMed ID: 31707767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose Modification of Etoposide plus Platinum in Elderly Patients with Extensive-Disease Small-Cell Lung Cancer.
    Kim H; Choi E; Heo MH; Kim JY; Park KU
    Oncology; 2022; 100(6):313-319. PubMed ID: 35390786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity.
    Ou SH; Ziogas A; Zell JA
    J Thorac Oncol; 2009 Jan; 4(1):37-43. PubMed ID: 19096304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consolidation radiotherapy for patients with extended disease small cell lung cancer in a single tertiary institution: impact of dose and perspectives in the era of immunotherapy.
    Stanic K; Vrankar M; But-Hadzic J
    Radiol Oncol; 2020 Jul; 54(3):353-363. PubMed ID: 32726294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment patterns and outcomes among patients with small-cell lung cancer (SCLC) in Europe: a retrospective cohort study.
    Blackhall F; Girard N; Livartowski A; McDonald L; Roset M; Lara N; Juarez García A
    BMJ Open; 2023 Feb; 13(2):e052556. PubMed ID: 36746549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of subsequent chemotherapy on the survival of elderly patients with extensive stage small cell lung cancer.
    Kang EJ; Choi YJ; Lee SR; Sung HJ; Kim JS
    Korean J Intern Med; 2020 Nov; 35(6):1468-1476. PubMed ID: 32336056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
    Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
    Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide.
    Rose L; Prins KW; Archer SL; Pritzker M; Weir EK; Misialek JR; Thenappan T
    J Heart Lung Transplant; 2019 Feb; 38(2):145-155. PubMed ID: 30391191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary function decreases moderately after accelerated high-dose irradiation for stage III non-small cell lung cancer.
    Grambozov B; Wolf F; Kaiser J; Wass R; Fastner G; Gaisberger C; Rettenbacher L; Studnicka M; Pirich C; Sedlmayer F; Zehentmayr F
    Thorac Cancer; 2020 Feb; 11(2):369-378. PubMed ID: 31855325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified Glasgow Prognostic Score as a Prognostic Factor in Patients with Extensive Disease-Small-Cell Lung Cancer: A Retrospective Study in a Single Institute.
    Sonehara K; Tateishi K; Komatsu M; Yamamoto H; Hanaoka M; Kanda S; Koizumi T
    Chemotherapy; 2019; 64(3):129-137. PubMed ID: 31622969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia.
    Shirasawa M; Fukui T; Kusuhara S; Hiyoshi Y; Nakahara Y; Nishinarita N; Igawa S; Naoki K
    BMC Cancer; 2019 Feb; 19(1):163. PubMed ID: 30808322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
    Shao N; Cai Q
    Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of small cell lung cancer patients treated with cisplatin-etoposide versus carboplatin-etoposide.
    Karam I; Jiang SY; Khaira M; Lee CW; Schellenberg D
    Am J Clin Oncol; 2015 Feb; 38(1):51-4. PubMed ID: 23563211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis.
    Eze C; Taugner J; Roengvoraphoj O; Schmidt-Hegemann NS; Käsmann L; Wijaya C; Belka C; Manapov F
    Radiat Oncol; 2019 Sep; 14(1):163. PubMed ID: 31484542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.